advertising
Link to jump to start of content The Seattle Times Company Jobs Autos Homes Rentals NWsource Classifieds seattletimes.com
The Seattle Times Business & Technology
Traffic | Weather | Your account Movies | Restaurants | Today's events

News, analysis and perspectives from the
technology team at The Seattle Times.
Have a news tip? Follow the links below to e-mail us.

All blogs and discussions:

Go

October 30, 2007

Nastech slips on Wall Street

Posted by Angel Gonzalez at 5:24 PM

Nastech Pharmaceuticals had a rough time in the market Tuesday in the wake of its most recent quarterly earnings report.

Shares fell 13.27 percent to $12.88 as the Bothell firm - which specializes in delivering therapies through its proprietary nasal spray technology - saw its quarterly loss more than double to $16.4 million.

Profits are not as meaningful in early-stage biomedical companies such as Nastech, which derive most of their income from research partnerships and investors, as they are in other, commercial-stage companies. But the sudden drop in the company's numbers seems to have spooked some shareholders.

The loss, the company said in an earnings statement Monday, came as lower revenue coincided with higher research expenditures and an expanded payroll.

Share:    Digg     Newsvine

Post/read Comments (0) »

Tricia Duryee
Tricia Duryee
E-mail|Bio


Angel Gonzalez
Angel Gonzalez
E-mail|Bio


Kristi Heim
Kristi Heim
E-mail|Bio


Benjamin J. Romano
Benjamin J. Romano
E-mail|Bio


Mark Watanabe
Mark
Watanabe

E-mail|Bio

Marketplace

advertising

advertising